No advantage of dexamethasone over predonisolone for the outcome of standard and intermediate risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study group L95-14 protocol.
書誌事項
- タイトル
- No advantage of dexamethasone over predonisolone for the outcome of standard and intermediate risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study group L95-14 protocol.
- 著者
- Igarashi S, Manabe A, Ohara A, Kumagai M, Saito T, Okimoto Y, Kamijo T, Isoyama K, Kajiwara M, Sotomatsu M, Sugita K, Sugita K, Maeda M, Yabe H, Kinoshita T, Kaneko T, Hayashi Y, Ikuta K, Hanada R, Tsuchiya M.
収録刊行物
-
- J Clin Oncol 20
-
J Clin Oncol 20 6489-6498, 2005
